Livedo Reticularis After COVID-19 Vaccination
J Rheumatol
.
2023 May;50(5):709.
doi: 10.3899/jrheum.220584.
Epub 2022 Oct 1.
Authors
Taro Horino
1
,
Satoshi Inotani
2
,
Kimiko Nakajima
3
,
Yoshio Terada
4
Affiliations
1
Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; horinott@yahoo.co.jp.
2
Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University.
3
Department of Dermatology, Kochi Medical School, Kochi University.
4
Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan.
PMID:
36182117
DOI:
10.3899/jrheum.220584
No abstract available
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Livedo Reticularis*
Vaccination
Substances
COVID-19 Vaccines